...
首页> 外文期刊>Journal of Clinical Microbiology >Comparison of the SPF10-LiPA System to the Hybrid Capture 2 Assay for Detection of Carcinogenic Human Papillomavirus Genotypes among 5,683 Young Women in Guanacaste, Costa Rica
【24h】

Comparison of the SPF10-LiPA System to the Hybrid Capture 2 Assay for Detection of Carcinogenic Human Papillomavirus Genotypes among 5,683 Young Women in Guanacaste, Costa Rica

机译:SPF10-LiPA系统与杂种捕获2检测法在哥斯达黎加瓜纳卡斯特的5683名年轻女性中检测致癌性人乳头瘤病毒基因型的比较

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The objective of this analysis was to compare the performance characteristics of two human papillomavirus (HPV) DNA detections assays, the Hybrid Capture 2 assay (HC2) and the SPF10 assay, for the detection of carcinogenic HPV. Data are from the enrollment visits of women who participated in the randomized, double-blind, placebo-controlled phase III HPV16/18 Vaccine Trial in Guanacaste, Costa Rica. We compared the results of HC2 and SPF10 testing of cervical specimens. Since the line probe assay (LiPA) detection system does not distinguish between HPV type 68 (HPV68; which is targeted by HC2) and HPV73 (which is not targeted by HC2), for SPF10-LiPA, we defined the carcinogenic HPV types as the 12 HC2-targeted types (types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, and 59), HPV68/73, and the HC2-cross-reactive, carcinogenic type HPV66. The kappa values and the performance characteristics for the detection of cervical abnormalities were ascertained. Paired observations were available for 5,683 sexually active, young women (median age, 21 years). The prevalence of carcinogenic HPV types was 35% (n = 1,962) by HC2 and 35% (n = 2,003) by SPF10-LiPA. There were no differences in the prevalence of carcinogenic HPV types by HC2 and SPF10-LiPA among women with normal, atypical squamous cells of undetermined significance and high-grade squamous intraepithelial lesion cytology. Among women with low-grade squamous intraepithelial lesion cytology, HC2 was more likely to test positive than SPF10-LiPA for the carcinogenic HPV types (87% and 79%, respectively; P = 0.001) as a result of HC2 cross-reactivity with HPV types 40, 43, 44, 53, 54, 60, 70, and 74. The crude agreement between the two assays was 88%, with a kappa value of 0.75 (95% confidence limits, 0.73 to 0.76). We observed very good agreement between HC2 and SPF10-LiPA for carcinogenic HPV type detection.
机译:本分析的目的是比较两种人类乳头瘤病毒(HPV)DNA检测方法,Hybrid Capture 2检测方法(HC2)和SPF 10 检测方法的性能特征,以检测致癌的HPV。数据来自参加在哥斯达黎加瓜纳卡斯特进行的随机,双盲,安慰剂对照的III期HPV16 / 18疫苗试验的女性的入组访问。我们比较了宫颈样本中HC2和SPF 10 的测试结果。由于线探针分析(LiPA)检测系统无法区分SPF 10 -LiPA的HPV类型68(HPV68;被HC2作为目标)和HPV73(未被HC2作为目标),我们将致癌的HPV类型定义为12种HC2靶向类型(16、18、31、33、35、39、45、51、52、56、58和59型),HPV68 / 73和HC2反应性致癌型HPV66。确定kappa值和检测宫颈异常的性能特征。配对观察可用于5683名性活跃的年轻女性(中位年龄为21岁)。 HC2致癌的HPV类型患病率为35%( n = 1,962),SPF 10 -LiPA为35%( n = 2,003) 。 HC2和SPF 10 -LiPA致癌的HPV类型的患病率在具有未确定的正常,非典型鳞状细胞和高度鳞状上皮内病变细胞学的女性中没有差异。在具有低级鳞状上皮内病变细胞学特征的女性中,对于致癌的HPV类型,HC2比SPF 10 -LiPA更有可能呈阳性反应(分别为87%和79%; P = 0.001)是HC2与HPV 40、43、44、53、54、60、70和74型交叉反应的结果。两次检测之间的粗略一致性为88%,kappa值为0.75 (95%的置信度范围为0.73至0.76)。我们观察到HC2和SPF 10 -LiPA在致癌性HPV类型检测中具有很好的一致性。

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号